+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Anti-Inflammatory Drugs Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Anti-Inflammatory Drugs Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Humira Biosimilar Global Market Report 2025 - Product Thumbnail Image

Humira Biosimilar Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
Axial Spondyloarthritis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Axial Spondyloarthritis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • July 2024
  • 231 Pages
  • Global
From
SIMPONI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
OLUMIANT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OLUMIANT Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENBREL Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENBREL Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SIMPONI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
HUMIRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HUMIRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
CIMZIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CIMZIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENTYVIO Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Anti-Inflammatory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Anti-Inflammatory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 150 Pages
  • Global
From
Sjogren's Syndrome - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Sjogren's Syndrome - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • April 2024
  • 202 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 137 Pages
  • Global
From
Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • February 2022
  • 210 Pages
  • Global
From
Japan Inflammatory Bowel Disease (IBD) Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

Japan Inflammatory Bowel Disease (IBD) Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • August 2024
  • 80 Pages
  • Japan
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more